A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis (clinicaltrials.gov) - May 9, 2024 - P3 | N=270 | Recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.
New P3 trial • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|